LA | |
---|---|
Post | - |
Pre | - |
M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|
0 | - | - | - | 0.3 | 16.0 | 888.0 | 306.7 | 5.3 | - | - | 1216.3 |
1 | - | - | - | - | - | 196.0 | 96.3 | 1.0 | - | - | 293.3 |
LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
---|---|---|---|---|---|---|---|---|
Post | - | - | - | - | - | - | - | - |
Pre | - | - | - | - | - | - | - | - |
AME | |
---|---|
0 | 63.3 |
1 | 3.3 |
LOP1 | LOP2 | LOP3 | LOP4 | Total | |
---|---|---|---|---|---|
Post | - | - | - | - | - |
Pre | - | - | - | - | - |
central brain | |
---|---|
0 | 537.7 |
1 | 821.3 |
Number of post synapses: 3649
Number of pre synapses: 880
Number of output connections: 2738
Coverage factor: 1.9
Columnar completeness: 0.55
Area completeness: 0.73
Cell size (columns): 308
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
instance | NT | total connections | connections /#aMe26 (R) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | MeTu1 (R) | ACh | 1,108 | 369.3 | 28.6% | 28.6% |
1 | Dm2 (R) | ACh | 461 | 153.7 | 11.9% | 40.5% |
2 | Cm3 (R) | GABA | 296 | 98.7 | 7.6% | 48.2% |
3 | Cm9 (R) | Glu | 262 | 87.3 | 6.8% | 54.9% |
4 | aMe2 (R) | Glu | 138 | 46.0 | 3.6% | 58.5% |
5 | MeLo3b (R) | ACh | 133 | 44.3 | 3.4% | 61.9% |
6 | MeVP6 (R) | Glu | 125 | 41.7 | 3.2% | 65.1% |
7 | MeVP14 (R) | ACh | 107 | 35.7 | 2.8% | 67.9% |
8 | Cm5 (R) | GABA | 100 | 33.3 | 2.6% | 70.5% |
9 | Tm34 (R) | Glu | 90 | 30.0 | 2.3% | 72.8% |
10 | Dm8a (R) | Glu | 89 | 29.7 | 2.3% | 75.1% |
11 | Mi15 (R) | ACh | 85 | 28.3 | 2.2% | 77.3% |
12 | Cm24 (R) | Glu | 72 | 24.0 | 1.9% | 79.2% |
13 | MeVP9 (R) | ACh | 65 | 21.7 | 1.7% | 80.8% |
14 | Cm4 (R) | Glu | 39 | 13.0 | 1.0% | 81.8% |
15 | Mi10 (R) | ACh | 37 | 12.3 | 1.0% | 82.8% |
16 | TmY17 (R) | ACh | 34 | 11.3 | 0.9% | 83.7% |
17 | MeVP45 (R) | ACh | 28 | 9.3 | 0.7% | 84.4% |
18 | MeLo5 (R) | ACh | 26 | 8.7 | 0.7% | 85.1% |
19 | MeVC7a (L) | ACh | 22 | 7.3 | 0.6% | 85.6% |
20 | MeVC8 (L) | ACh | 22 | 7.3 | 0.6% | 86.2% |
21 | MeVP8 (R) | ACh | 21 | 7.0 | 0.5% | 86.8% |
22 | MeVC20 (R) | Glu | 19 | 6.3 | 0.5% | 87.2% |
23 | MeVC_unclear (R) | Glu | 18 | 6.0 | 0.5% | 87.7% |
24 | MeVP20 (R) | unclear | 18 | 6.0 | 0.5% | 88.2% |
25 | aMe5 (R) | ACh | 17 | 5.7 | 0.4% | 88.6% |
26 | MeVP15 (R) | ACh | 16 | 5.3 | 0.4% | 89.0% |
27 | Tm5c (R) | Glu | 16 | 5.3 | 0.4% | 89.4% |
28 | OA-AL2i4 (R) | OA | 15 | 5.0 | 0.4% | 89.8% |
29 | Cm14 (R) | GABA | 14 | 4.7 | 0.4% | 90.2% |
30 | MeVC3 (L) | ACh | 14 | 4.7 | 0.4% | 90.5% |
31 | aMe1 (R) | GABA | 13 | 4.3 | 0.3% | 90.9% |
32 | aMe12 (R) | ACh | 13 | 4.3 | 0.3% | 91.2% |
33 | MeLo1 (R) | ACh | 13 | 4.3 | 0.3% | 91.6% |
34 | MeVC27 (L) | unclear | 13 | 4.3 | 0.3% | 91.9% |
35 | Cm12 (R) | GABA | 12 | 4.0 | 0.3% | 92.2% |
36 | Cm1 (R) | ACh | 11 | 3.7 | 0.3% | 92.5% |
37 | MeTu3c (R) | ACh | 11 | 3.7 | 0.3% | 92.8% |
38 | MeVPLo2 (R) | ACh | 11 | 3.7 | 0.3% | 93.1% |
39 | MeVPMe4 (L) | Glu | 11 | 3.7 | 0.3% | 93.3% |
40 | aMe4 (R) | ACh | 10 | 3.3 | 0.3% | 93.6% |
41 | aMe30 (R) | Glu | 9 | 3.0 | 0.2% | 93.8% |
42 | Cm25 (R) | Glu | 9 | 3.0 | 0.2% | 94.1% |
43 | Cm6 (R) | GABA | 9 | 3.0 | 0.2% | 94.3% |
44 | MeLo6 (R) | ACh | 8 | 2.7 | 0.2% | 94.5% |
45 | MeVP12 (R) | ACh | 8 | 2.7 | 0.2% | 94.7% |
46 | TmY20 (R) | ACh | 8 | 2.7 | 0.2% | 94.9% |
47 | 5thsLNv_LNd6 (R) | ACh | 7 | 2.3 | 0.2% | 95.1% |
48 | aMe6b (R) | ACh | 7 | 2.3 | 0.2% | 95.3% |
49 | Cm27 (R) | Glu | 7 | 2.3 | 0.2% | 95.5% |
50 | MeTu4c (R) | ACh | 7 | 2.3 | 0.2% | 95.6% |
51 | aMe26 (R) | ACh | 6 | 2.0 | 0.2% | 95.8% |
52 | Cm8 (R) | GABA | 6 | 2.0 | 0.2% | 95.9% |
53 | Dm-DRA2 (R) | Glu | 6 | 2.0 | 0.2% | 96.1% |
54 | Lat3 (R) | unclear | 6 | 2.0 | 0.2% | 96.3% |
55 | aMe23 (R) | unclear | 5 | 1.7 | 0.1% | 96.4% |
56 | Cm16 (R) | Glu | 5 | 1.7 | 0.1% | 96.5% |
57 | Cm21 (R) | GABA | 5 | 1.7 | 0.1% | 96.6% |
58 | Dm-DRA1 (R) | Glu | 5 | 1.7 | 0.1% | 96.8% |
59 | MeTu4a (R) | ACh | 5 | 1.7 | 0.1% | 96.9% |
60 | Cm23 (R) | Glu | 4 | 1.3 | 0.1% | 97.0% |
61 | Cm30 (R) | GABA | 4 | 1.3 | 0.1% | 97.1% |
62 | MeVP33 (R) | ACh | 4 | 1.3 | 0.1% | 97.2% |
63 | MeVPOL1 (R) | ACh | 4 | 1.3 | 0.1% | 97.3% |
64 | Tm5a (R) | ACh | 4 | 1.3 | 0.1% | 97.4% |
65 | aMe12 (L) | ACh | 3 | 1.0 | 0.1% | 97.5% |
66 | aMe15 (R) | unclear | 3 | 1.0 | 0.1% | 97.6% |
67 | aMe22 (R) | Glu | 3 | 1.0 | 0.1% | 97.7% |
68 | Ascending_TBD1 (R) | unclear | 3 | 1.0 | 0.1% | 97.7% |
69 | Cm10 (R) | GABA | 3 | 1.0 | 0.1% | 97.8% |
70 | Cm18 (R) | Glu | 3 | 1.0 | 0.1% | 97.9% |
71 | Cm31b (R) | GABA | 3 | 1.0 | 0.1% | 98.0% |
72 | Cm33 (R) | GABA | 3 | 1.0 | 0.1% | 98.0% |
73 | Lat1 (R) | unclear | 3 | 1.0 | 0.1% | 98.1% |
74 | Li29 (R) | GABA | 3 | 1.0 | 0.1% | 98.2% |
instance | NT | total connections | connections /#aMe26 (R) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | Cm3 (R) | GABA | 842 | 280.7 | 29.9% | 29.9% |
1 | Cm12 (R) | GABA | 509 | 169.7 | 18.1% | 48.0% |
2 | Cm8 (R) | GABA | 152 | 50.7 | 5.4% | 53.4% |
3 | MeVC27 (L) | unclear | 146 | 48.7 | 5.2% | 58.6% |
4 | Mi17 (R) | GABA | 113 | 37.7 | 4.0% | 62.6% |
5 | Cm6 (R) | GABA | 109 | 36.3 | 3.9% | 66.5% |
6 | Cm16 (R) | Glu | 99 | 33.0 | 3.5% | 70.0% |
7 | Dm2 (R) | ACh | 80 | 26.7 | 2.8% | 72.9% |
8 | Tm37 (R) | Glu | 72 | 24.0 | 2.6% | 75.4% |
9 | MeVP9 (R) | ACh | 54 | 18.0 | 1.9% | 77.4% |
10 | Cm5 (R) | GABA | 50 | 16.7 | 1.8% | 79.1% |
11 | MeTu4c (R) | ACh | 44 | 14.7 | 1.6% | 80.7% |
12 | MeVP59 (R) | ACh | 41 | 13.7 | 1.5% | 82.2% |
13 | Lat3 (R) | unclear | 40 | 13.3 | 1.4% | 83.6% |
14 | OA-AL2i4 (R) | OA | 37 | 12.3 | 1.3% | 84.9% |
15 | Cm4 (R) | Glu | 32 | 10.7 | 1.1% | 86.0% |
16 | Tm34 (R) | Glu | 29 | 9.7 | 1.0% | 87.1% |
17 | Tm5c (R) | Glu | 29 | 9.7 | 1.0% | 88.1% |
18 | MeVPaMe2 (R) | Glu | 22 | 7.3 | 0.8% | 88.9% |
19 | Tm35 (R) | Glu | 19 | 6.3 | 0.7% | 89.5% |
20 | aMe4 (R) | ACh | 18 | 6.0 | 0.6% | 90.2% |
21 | MeVPLo2 (R) | ACh | 18 | 6.0 | 0.6% | 90.8% |
22 | MeTu1 (R) | ACh | 15 | 5.0 | 0.5% | 91.4% |
23 | Mi10 (R) | ACh | 15 | 5.0 | 0.5% | 91.9% |
24 | MeVP45 (R) | ACh | 13 | 4.3 | 0.5% | 92.4% |
25 | MeVP55 (R) | unclear | 13 | 4.3 | 0.5% | 92.8% |
26 | 5thsLNv_LNd6 (R) | ACh | 12 | 4.0 | 0.4% | 93.2% |
27 | MeVC20 (R) | Glu | 11 | 3.7 | 0.4% | 93.6% |
28 | Cm22 (R) | GABA | 9 | 3.0 | 0.3% | 94.0% |
29 | MeVPMe12 (R) | ACh | 9 | 3.0 | 0.3% | 94.3% |
30 | Cm11c (R) | ACh | 7 | 2.3 | 0.2% | 94.5% |
31 | 5-HTPMPV03 (R) | 5HT | 6 | 2.0 | 0.2% | 94.7% |
32 | aMe26 (R) | ACh | 6 | 2.0 | 0.2% | 95.0% |
33 | MeTu4a (R) | ACh | 6 | 2.0 | 0.2% | 95.2% |
34 | MeVPMe5 (R) | Glu | 6 | 2.0 | 0.2% | 95.4% |
35 | Mi15 (R) | ACh | 6 | 2.0 | 0.2% | 95.6% |
36 | SLP250 (R) | unclear | 6 | 2.0 | 0.2% | 95.8% |
37 | Cm30 (R) | GABA | 5 | 1.7 | 0.2% | 96.0% |
38 | MeLo5 (R) | ACh | 5 | 1.7 | 0.2% | 96.2% |
39 | MeVP6 (R) | Glu | 5 | 1.7 | 0.2% | 96.3% |
40 | Cm1 (R) | ACh | 4 | 1.3 | 0.1% | 96.5% |
41 | l-LNv (R) | unclear | 4 | 1.3 | 0.1% | 96.6% |
42 | MeLo6 (R) | ACh | 4 | 1.3 | 0.1% | 96.8% |
43 | MeTu3b (R) | ACh | 4 | 1.3 | 0.1% | 96.9% |
44 | MeVP49 (R) | unclear | 4 | 1.3 | 0.1% | 97.0% |
45 | Mi16 (R) | GABA | 4 | 1.3 | 0.1% | 97.2% |
46 | 5-HTPMPV03 (L) | 5HT | 3 | 1.0 | 0.1% | 97.3% |
47 | Cm-DRA (R) | ACh | 3 | 1.0 | 0.1% | 97.4% |
48 | Cm10 (R) | GABA | 3 | 1.0 | 0.1% | 97.5% |
49 | SLP249 (R) | unclear | 3 | 1.0 | 0.1% | 97.6% |
50 | TmY10 (R) | ACh | 3 | 1.0 | 0.1% | 97.7% |